Literature DB >> 33640887

A Putative Adverse Outcome Pathway Network for Disrupted Female Pubertal Onset to Improve Testing and Regulation of Endocrine Disrupting Chemicals.

Delphine Franssen1, Terje Svingen2, David Lopez Rodriguez1, Majorie Van Duursen3, Julie Boberg2, Anne-Simone Parent1,4.   

Abstract

The average age for pubertal onset in girls has declined over recent decades. Epidemiological studies in humans and experimental studies in animals suggest a causal role for endocrine disrupting chemicals (EDCs) that are present in our environment. Of concern, current testing and screening regimens are inadequate in identifying EDCs that may affect pubertal maturation, not least because they do not consider early-life exposure. Also, the causal relationship between EDC exposure and pubertal timing is still a matter of debate. To address this issue, we have used current knowledge to elaborate a network of putative adverse outcome pathways (pAOPs) to identify how chemicals can affect pubertal onset. By using the AOP framework, we highlight current gaps in mechanistic understanding that need to be addressed and simultaneously point towards events causative of pubertal disturbance that could be exploited for alternative test methods. We propose 6 pAOPs that could explain the disruption of pubertal timing by interfering with the central hypothalamic trigger of puberty, GnRH neurons, and by so doing highlight specific modes of action that could be targeted for alternative test method development.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Adverse outcome pathway; Endocrine disrupting chemicals; Hypothalamic-pituitary-gonadal axis; Puberty; Reproduction

Mesh:

Substances:

Year:  2021        PMID: 33640887     DOI: 10.1159/000515478

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  2 in total

Review 1.  Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands.

Authors:  Filippo Egalini; Lorenzo Marinelli; Mattia Rossi; Giovanna Motta; Nunzia Prencipe; Ruth Rossetto Giaccherino; Loredana Pagano; Silvia Grottoli; Roberta Giordano
Journal:  Endocrine       Date:  2022-05-23       Impact factor: 3.925

2.  A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation.

Authors:  Terje Svingen; Daniel L Villeneuve; Dries Knapen; Eleftheria Maria Panagiotou; Monica Kam Draskau; Pauliina Damdimopoulou; Jason M O'Brien
Journal:  Toxicol Sci       Date:  2021-11-24       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.